Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaewon Oh

Showing results (21-30 of 201) with videos related to

Pageof 21
Sort By:
The New England Journal of Medicine|December 6, 2013
Riociguat for pulmonary hypertensionJaewon Oh, Jong-Chan Youn, Seok-Min Kang
JAMA|November 12, 2009
Outcomes in patients with prolonged PR interval or first-degree atrioventricular blockJaewon Oh, Ho Youn Won, Seok-Min Kang
Lancet (London, England)|December 21, 2010
Ivabradine and outcomes in chronic heart failureSeok-Min Kang, Hoyoun Won, Namki Hong, et al.
Lancet (London, England)|July 4, 2006
Autologous bone-marrow stem cells for myocardial infarctionJaewon Oh, Hyunseok Kang, Ji Hyung Chung, et al.
Scientific Reports|July 2, 2025
Comparison of the 2021 ESC guideline with the HFA-PEFF and H<sub>2</sub>FPEF scores in diagnosing heart failure with preserved ejection fractionMinjae Yoon, Jaewon Oh, Chan Joo Lee, et al.
Korean Circulation Journal|August 4, 2022
A Case of SCN5A Mutation-Associated Isolated Left Atrial Standstill and Ischemic StrokeDong-Seon Kang, Pichmanil Khmao, Jaewon Oh, et al.
International Journal of Heart Failure|November 8, 2024
Trends of Left Ventricular Assist Device Implantation and Heart Transplantation in KoreaMin-Seok Kim, Jaewon Oh, Jin-Oh Choi, et al.
Korean Circulation Journal|May 11, 2021
Sodium-glucose Co-transporter 2 Inhibitors: a New Path for Heart Failure TreatmentJaewon Oh, Seung Hyun Lee, Chan Joo Lee, et al.
Scientific Reports|June 11, 2022
Real-world experience of angiotensin receptor neprilysin inhibitor on the glucose-lowering effectHeungjo Kim, Gyunam Park, Jongsung Hahn, et al.
ESC Heart Failure|April 3, 2023
Factors influencing left ventricular thrombus resolution and its significance on clinical outcomesSe-Eun Kim, Chan Joo Lee, Jaewon Oh, et al.
Pageof 21

Showing results (21-30 of 201) with videos related to

Sort By:
Pageof 21
The New England Journal of Medicine|December 6, 2013
Riociguat for pulmonary hypertensionJaewon Oh, Jong-Chan Youn, Seok-Min Kang
JAMA|November 12, 2009
Outcomes in patients with prolonged PR interval or first-degree atrioventricular blockJaewon Oh, Ho Youn Won, Seok-Min Kang
Lancet (London, England)|December 21, 2010
Ivabradine and outcomes in chronic heart failureSeok-Min Kang, Hoyoun Won, Namki Hong, et al.
Lancet (London, England)|July 4, 2006
Autologous bone-marrow stem cells for myocardial infarctionJaewon Oh, Hyunseok Kang, Ji Hyung Chung, et al.
Scientific Reports|July 2, 2025
Comparison of the 2021 ESC guideline with the HFA-PEFF and H<sub>2</sub>FPEF scores in diagnosing heart failure with preserved ejection fractionMinjae Yoon, Jaewon Oh, Chan Joo Lee, et al.
Korean Circulation Journal|August 4, 2022
A Case of SCN5A Mutation-Associated Isolated Left Atrial Standstill and Ischemic StrokeDong-Seon Kang, Pichmanil Khmao, Jaewon Oh, et al.
International Journal of Heart Failure|November 8, 2024
Trends of Left Ventricular Assist Device Implantation and Heart Transplantation in KoreaMin-Seok Kim, Jaewon Oh, Jin-Oh Choi, et al.
Korean Circulation Journal|May 11, 2021
Sodium-glucose Co-transporter 2 Inhibitors: a New Path for Heart Failure TreatmentJaewon Oh, Seung Hyun Lee, Chan Joo Lee, et al.
Scientific Reports|June 11, 2022
Real-world experience of angiotensin receptor neprilysin inhibitor on the glucose-lowering effectHeungjo Kim, Gyunam Park, Jongsung Hahn, et al.
ESC Heart Failure|April 3, 2023
Factors influencing left ventricular thrombus resolution and its significance on clinical outcomesSe-Eun Kim, Chan Joo Lee, Jaewon Oh, et al.
Pageof 21